Posts

Showing posts with the label Primary Biliary Cirrhosis Drugs Manufacturers

Primary Biliary Cirrhosis Drugs Market Business Segmentation By Revenue And Structure Forecast 2027

Image
  Primary biliary cirrhosis (PBC) also called primary biliary cholangitis is an autoimmune disease of liver, which causes liver inflammation, fibrosis, and obstruction in the bile duct leading to destruction of small bile ducts within liver. PBC causes autoimmunity, infection and/or genetic predisposition. The primary symptoms of primary biliary cirrhosis are itching, osteoporosis, elevated serum cholesterol, and malabsorption of fat and fat soluble vitamins, which can advance to hepatomegaly, hyperpigmentation, splenomegaly, jaundice, sicca syndrome or Kayser-Fleischer rings. Primary Biliary Cirrhosis Drugs Market The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. Various non-profit organizations are also operating awareness programs and funding research on novel therapies to treat the condition. This will foster market growth. The Global Prima

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides